Matira™ Anterior Cervical System

K172086 · Kalitec Direct, LLC · KWQ · Sep 22, 2017 · Orthopedic

Device Facts

• Record ID: K172086
• Device Name: Matira™ Anterior Cervical System
• Applicant: Kalitec Direct, LLC
• Product Code: KWQ · Orthopedic
• Decision Date: Sep 22, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3060
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Matira™ Anterior Cervical System is interior interbody screw fixation of the cervical spine from C2 to Tl. The system is indicated for use in the temporary stabilization of the anterior spine as an adjunct to fusion for patients with degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), trauma (including fractures and dislocations), tumors, spondylolisthesis, deformity (defined as kyphosis, lordosis), spinal stenosis, pseudarthrosis, and/or failed previous fusions. This device system is intended for anterior cervical intervertebral body fusions only.

Device Story

Matira Anterior Cervical System is a temporary spinal fixation implant set; includes bone plates and screws (fixed/variable, self-drilling/self-tapping configurations). Used by surgeons in clinical settings to provide temporary stabilization of the anterior cervical spine (C2-T1) during fusion procedures. Implants are secured to the vertebral body to maintain space and stability until biological fusion occurs. System includes associated surgical instruments for implantation. Benefits include stabilization of the spine in patients with degenerative, traumatic, or neoplastic conditions.

Clinical Evidence

No clinical studies were performed. Equivalence established via non-clinical bench testing.

Technological Characteristics

Implants: Ti-6Al-4V ELI (ASTM F136). Instruments: 17-4 H900 SS or 465 SS H950 (ASTM F899). Mechanical fixation via plates and screws. No software or energy source.

Indications for Use

Indicated for patients requiring temporary anterior cervical spine stabilization (C2-T1) as an adjunct to fusion. Conditions include degenerative disc disease, trauma (fractures/dislocations), tumors, spondylolisthesis, deformity (kyphosis, lordosis), spinal stenosis, pseudarthrosis, and failed previous fusions. Contraindicated for posterior element (pedicle) attachment.

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

• Ocata Anterior Cervical System™ (K170342)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/2 description: The image is a logo for the U.S. Department of Health & Human Services. The logo features a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with the profiles overlapping each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

September 22, 2017

Kalitec Direct, LLC % Mr. Justin Eggleton Senior Director, Spine Regulatory Affairs Musculoskeletal Clinical Regulatory Advisers. LLC 1050 K Street Northwest. Suite 1000 Washington, District of Columbia 20001

Re: K172086

Trade/Device Name: Matira™ Anterior Cervical System Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal Intervertebral Body Fixation Orthosis Regulatory Class: Class II Product Code: KWO Dated: September 8, 2017 Received: September 11, 2017

Dear Mr. Eggleton:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

Katherine D. Kavlock -

Image /page/1/Picture/10 description: The image contains a single, large, uppercase letter 'S'. The letter is black and appears to be a sans-serif font. The background is plain white, providing a stark contrast to the letter.

for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K172086

Device Name Matira™ Anterior Cervical System

#### Indications for Use (Describe)

The Matira™ Anterior Cervical System is interior interbody screw fixation of the cervical spine from C2 to Tl. The system is indicated for use in the temporary stabilization of the anterior spine as an adjunct to fusion for patients with degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), trauma (including fractures and dislocations), tumors, spondylolisthesis, deformity (defined as kyphosis, lordosis), spinal stenosis, pseudarthrosis, and/or failed previous fusions. This device system is intended for anterior cervical intervertebral body fusions only.

WARNING: This device is not approved for screw attachment to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.

Type of Use (Select one or both, as applicable)

| <div> <span> <span style="font-size: 16px;">☑</span> Prescription Use (Part 21 CFR 801 Subpart D) </span> </div> |
|----------------------------------------------------------------------------------------------------------------------------------|
| <div> <span> <span style="font-size: 16px;">☐</span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> </div> |

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) Summary for the Matira™ Anterior Cervical System

In accordance with 21 CFR 807.92 of the Federal Code of Regulations

| Date Prepared | July 6, 2017 |
|---------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Submitted by | Scott Winn<br>Kalitec Direct, LLC<br>618 E. South Street, Suite 500<br>Orlando, FL 32801<br>407-545-2063 Tele<br>407-358-5441 Fax |
| Primary Contact | Mr. Justin Eggleton<br>Senior Director, Spine Requlatory Affairs<br>Musculoskeletal Clinical Regulatory Advisers, LLC<br>1050 K Street Northwest, Suite 1000<br>Washington, District of Columbia 20001<br>202-552-5800 Tele<br>e-mail: [e-mail] |
| Secondary Contact | Keith Cannan<br>1890 W. CR 419, Suite 2000<br>Oviedo, FL 32765<br>407-545-2063 Tele<br>407-358-5441 Fax<br>e-mail: [e-mail] |
| Trade Name | Matira™ Anterior Cervical System |
| Common Name | Anterior Cervical Plate System |
| Classification Name | Appliance, Fixation, Spinal Intervertebral Body |
| | |
| Class | 11 |
| Product Code | KWQ |
| CFR Section | 21 CFR section 888.3060 |
| Device Panel | Orthopedic |
| Primary Predicate Device | Ocata Anterior Cervical System™ (K170342) |
| Secondary Predicate Devices | None |
| Device Description | The Matira Anterior Cervical System components are temporary implants<br>that are intended for anterior interbody screw fixation of the cervical spine<br>during the development of a cervical spinal fusion.<br>The Matira Anterior Cervical System consists of a variety of shapes and<br>sizes of bone plates, screws (available in self-drilling or self-tapping, fixed<br>or variable configurations), and associated instruments.<br>Bone screws inserted into the vertebral body of the cervical spine using |
| | System implant components are made from titanium alloy. |
| Materials | Implants are made from Ti-6AI-4V ELI conforming to ASTM F136.<br>System specific instruments are made from either 17-4 H900 SS or 465<br>SS H950 conforming to ASTM F899 |
| Intended Use | Maintain adequate space until fusion occurs. |
| Substantial Equivalence<br>Claimed to Predicate Devices | The Matira Anterior Cervical System™ is substantially equivalent to the<br>predicate devices in terms of intended use, design, materials used,<br>mechanical safety and performances. |
| Indications for Use | The Matira Anterior Cervical System is intended for anterior interbody<br>screw fixation of the cervical spine from C2 to T1. The system is indicated<br>for use in the temporary stabilization of the anterior spine as an adjunct to<br>fusion for patients with degenerative disc disease (as defined by neck<br>pain of discogenic origin with degeneration of the disc confirmed by<br>patient history and radiographic studies), trauma (including fractures and<br>dislocations), tumors, spondylolisthesis, deformity (defined as kyphosis,<br>lordosis, or scoliosis), spinal stenosis, pseudarthrosis, and/or failed<br>previous fusions. This device system is intended for anterior cervical<br>intervertebral body fusions only.<br>WARNING: This device is not approved for screw attachment to the<br>posterior elements (pedicles) of the cervical, thoracic, or lumbar spine. |
| Non-clinical Test Summary | The following analyses were conducted:<br>●<br>Plates were tested for static and dynamic compression<br>and torsion per ASTM F1717<br>Screws were tested for torsional yield strength, driving torque,<br>●<br>and axial pullout strength per ASTM F543<br>The results of these evaluations indicate that the Matira Anterior Cervical<br>System is equivalent to predicate devices. |
| Clinical Test Summary | No clinical studies were performed. |
| Conclusions: Non-clinical and<br>Clinical | Kalitec Direct, LLC considers the Matira Anterior Cervical System to be<br>equivalent to the predicate devices listed above. This conclusion is based<br>upon the devices' similarities in principles of operation, technology,<br>materials and indications for use. |

{4}------------------------------------------------